Enzo Biochem, Inc. (ENZB)
OTCMKTS · Delayed Price · Currency is USD
0.6989
+0.0114 (1.65%)
Inactive · Last trade price on Aug 19, 2025
Enzo Biochem Employees
As of July 31, 2024, Enzo Biochem had 136 total employees, including 125 full-time and 11 part-time employees. The number of employees decreased by 54 or -28.42% compared to the previous year.
Employees
136
Change (1Y)
-54
Growth (1Y)
-28.42%
Revenue / Employee
$209,725
Profits / Employee
-$160,931
Market Cap
36.59M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Jul 31, 2024 | 136 | -54 | -28.42% |
| Jul 31, 2023 | 190 | -330 | -63.46% |
| Jul 31, 2022 | 520 | 6 | 1.17% |
| Jul 31, 2021 | 514 | 66 | 14.73% |
| Jul 31, 2020 | 448 | -52 | -10.40% |
| Jul 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jul 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jul 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jul 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jul 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Enzo Biochem News
- 13 days ago - Battery Ventures Completes Take-Private of Enzo Biochem - Business Wire
- 6 weeks ago - URGENT: The M&A Class Action Firm Encourages $hareholders to Act Before Vote - Enzo Biochem, Inc. (OTCMKTS: ENZB) - GlobeNewsWire
- 2 months ago - $HAREHOLDER ALERT: Class Action Attorney Juan Monteverde Investigates the Merger of Enzo Biochem, Inc. (OTCMKTS: ENZB) - GlobeNewsWire
- 2 months ago - ENZO BIOCHEM INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Enzo Biochem, Inc. - ENZB - Business Wire
- 2 months ago - ENZB Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Enzo Biochem, Inc. Is Fair to Shareholders - Business Wire
- 2 months ago - Enzo Biochem, Inc. To be Acquired by Battery Ventures in All-Cash Transaction - GlobeNewsWire
- 3 months ago - Enzo Biochem Reports Third Quarter Fiscal Year 2025 Results - GlobeNewsWire
- 5 months ago - Enzo Biochem, Inc. Announces Review of Strategic Alternatives after Receiving Multiple Inquiries Regarding a Potential Transaction - GlobeNewsWire